PCN75 Survival and Costs in Metastatic Renal Cell Carcinoma- A Comparison of mRCC Treatment Pre- and Post Tyrosine Kinase Inhibitor (TKI) Introduction Using Retrospective Registry Data

Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2115
https://www.valueinhealthjournal.com/article/S1098-3015(12)03829-6/fulltext
Section Title : Cancer
Section Order : 768
First Page : A422
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03829-6&doi=10.1016/j.jval.2012.08.2115
HEOR Topics :
Tags :
Regions :